$145.55

-2.23%

MRNA

Moderna, Inc.

•Healthcare

Biotech

mRNA Platform

High Short Interest

Overbought Momentum

Biotech

mRNA Platform

High Short Interest

Overbought Momentum

Loading Chart...

FIT ANALYSIS

Required for personalization

FIT ANALYSIS

Checking Membership...

STOCK DNA

Valuation

7/10

Quality

3/10

Growth

3/10

Strength

4/10

Dividend

1/10

Similar Stocks

BNTX BioNTech SE

ARCT Arcturus Therapeutics Holdings

BIIB Biogen Inc.

SRPT Sarepta Therapeutics, Inc.

REGN Regeneron Pharmaceuticals, Inc.

Health Indicators

Price Trend

Upwards

Momentum

Stretched

Balance Sheet

Healthy

Earnings

Stable

Dividend Yield

0.00%

Market Cap

$58.11B

TALK TO YOUR STOCK

EQUITAI ASSISTANT

Moderna is a biotechnology company that develops therapeutics and vaccines based on messenger RNA technology. Its core business focuses on infectious diseases, immuno-oncology, and rare genetic disorders. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?

AI can make mistakes. Verify important information.

Talk to Your Stock•open live chat

Pro EquitAI Research

Retrieving premium status...